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Introduction: Non-adherence to therapeutic is a widespread problem that
contributes to the worsening of chronic diseases and to increase the
expenditure on health care [1-3].
Objective: To present a review of the literature on the subject ‘‘Adherence
to therapy’’ in outpatients.
Methods: A search was carried out in the Medline database and the
combinations of words Medication, Adherence and Outpatients were used
for the period from 2010 to 2017. including only articles that adopted the
Morisky Medication Adherence Scale (MMAS) to measure adherence to
medication and studies developed in hospital context. In addition, articles
with non-conventional therapies were excluded, namely those that resorted
to the use of medicinal plants. Information was collected on the place of
the study, period, type of study, sample, pathology, adherence to therapy
in terms of rate or score (mean) and factors identiﬁed as being associated
with non-adherence to therapy.
Results: The search retrieved 461 publications and 44 were included in
the analysis. The included studies are from Europe, Asia, Africa and
America. Most of the studies were observational (84.1%). The remaining
studies were interventional studies (15.9%). There were, also, 4 multi-
center studies. In most studies, theMorisky scale was used with 8 item and
only 31.8% used the shorter scale with 4 items. The sample sizes ranged
from 34 to 2595 chronic patients and were mostly non-probabilistic
(convenience) (75%). The most common pathologies were: diabetes,
hypertension, diabetic retinopathy and hypercholesterolemia (34.1%);
psychiatric diseases (25%), cardiovascular diseases (18.2%), among oth-
ers. Taking into account the variable ‘‘adherence to therapeutic’’, 84.5% of
the studies used a dichotomous variable. The others determined the score
(mean with associated standard deviation). In general, therapeutic adher-
ence was low. Considering the adherence rates, the lowest were recorded
in the treatment of hypercholesterolemia (7.4%) and the highest was
recorded in the treatment of hypertension in patients with apnea (83%). It
should be noted that the cut-off point did not remain the same in all
studies. The factors most commonly referred to as being associated with
non-adherence were age, forgetfulness, lack of social support, the com-
plexity of intake and stopping medication when the patient feels better.
Conclusion: Interventional studies show signiﬁcant improvements in
adherence, comparing the situation before and after the intervention. There-
fore, it is a priority to implementmeasures that improve adherence to therapy.
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Introduction: Detecting adverse drug reactions (ADRs) is an important
task that has direct implications for the use of that drug for patients,
pharmaceutical companies, health organisations and regulators. A
promising approach for detecting ADRs is to use social media. A high
level of correlation between a drug name and an ADR can be regarded as
an indication of a potential ADR associated with that drug. Although
numerous association measures have been proposed in the signal detection
community for identifying ADRs, these measures tend to ignore causality.
Aim: Our aim was to develop a causality measure that can detect an
adverse reaction caused by a drug rather than merely being a correlated
signal.
Methods: We represented the relationship between a drug and an ADR
using a set of automatically extracted lexical patterns. We proposed a
novel signal detection problem where given a social media post T that
contains a drug D and an ADR R, we would like to determine whether R is
related to D, or otherwise. We then learn real-valued weights for the
extracted lexical patterns that indicate their reliability for expressing an
ADR of a given drug.
Results:We obtained an ADR detection accuracy of 74% on a large-scale
manually annotated dataset of tweets, covering a standard set of drugs and
ADRs. Moreover, intuitive lexical patterns that describe possibilities of
the occurrence of an ADR were captured by the proposed method.
Conclusions: To the best of our knowledge, ours is the ﬁrst causality-
sensitive approach for detecting ADRs from social media. Our results
show that the proposed method signiﬁcantly outperforms several com-
petitive baselines and a bag-of-words classiﬁer. Moreover, both midﬁx as
well as preﬁx information extracted from social media posts provide
useful information for the classiﬁer.
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